Literature DB >> 25176314

Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma.

Tong-Chun Xue1, Jing-Huai Zou1, Rong-Xin Chen1, Jie-Feng Cui1, Zhao-You Tang1, Sheng-Long Ye1.   

Abstract

The model of Notch-driven carcinogenesis and development of hepatocellular carcinoma remains controversial and is based on observations of developmental stage- and dose-dependent Notch activation. In this study, the relevance of the spatial distribution of Notch cascade members to the promotion of hepatocellular carcinoma metastasis was evaluated. The spatial expression patterns of the members of the Jagged1 (JAG1)/Notch1 cascade in HCC were evaluated in a tissue microarray of 112 tumors and 46 peri-tumors. Regulation of JAG1/Notch1 on osteopontin (OPN) was evaluated by RNA interference. Tumor cells with JAG1 expressed on the membrane (JAG1(Mem)) were more likely to undergo extrahepatic metastasis [p<0.001; hazard ratio (HR), 0.166; 95% CI, 0.068-0.402], and JAG1(Mem) was a strong independent prognostic factor for metastasis (HR, 0.467; 95% CI, 0.271-0.806; p=0.006). JAG1(Mem) also showed a strong positive correlation with Notch1(Mem). In addition, tumors with JAG1(Mem) expression had more poorly encapsulated membranes (p=0.014). Furthermore, Notch1(Mem) expression correlated with HCC metastasis and was the strongest predictive factor for metastasis. However, in peri-tumoral tissues, most JAG1 (45/46) and Notch1 (41/46) was localized to the cytoplasm. The expression of OPN, one of the main targets of JAG1/Notch1 signaling and a crucial metastasis-related gene in HCC, correlated significantly with JAG1(Mem) expression. Knockdown of JAG1 expression or Notch1 expression induced the downregulation of OPN in HCC cells. Taken together, protein localization is a critical factor affecting the activity of the Notch cascade in the development of hepatocellular carcinoma. Furthermore, our results suggest that the JAG1/Notch1/OPN cascade represents a potential therapeutic target for hepatocellular carcinoma metastasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25176314     DOI: 10.3892/ijo.2014.2630

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Epigenetic aberrations of gene expression in a rat model of hepatocellular carcinoma.

Authors:  Cayla Boycott; Megan Beetch; Tony Yang; Katarzyna Lubecka; Yuexi Ma; Jiaxi Zhang; Lucinda Kurzava Kendall; Melissa Ullmer; Benjamin S Ramsey; Sandra Torregrosa-Allen; Bennett D Elzey; Abigail Cox; Nadia Atallah Lanman; Alisa Hui; Nathaniel Villanueva; Aline de Conti; Tao Huan; Igor Pogribny; Barbara Stefanska
Journal:  Epigenetics       Date:  2022-05-03       Impact factor: 4.861

2.  Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.

Authors:  Fang-Hui Ren; Hong Yang; Rong-Quan He; Jing-Ning Lu; Xing-Gu Lin; Hai-Wei Liang; Yi-Wu Dang; Zhen-Bo Feng; Gang Chen; Dian-Zhong Luo
Journal:  BMC Cancer       Date:  2018-01-03       Impact factor: 4.430

Review 3.  Prognostic value of osteopontin in patients with hepatocellular carcinoma: A systematic review and meta-analysis.

Authors:  Tingting Sun; Peng Li; Diwen Sun; Qingao Bu; Guoqiang Li
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

4.  Long Non-coding RNA Expression Profiling Identifies a Four-Long Non-coding RNA Prognostic Signature for Isocitrate Dehydrogenase Mutant Glioma.

Authors:  Yusheng Chen; Yang Guo; Hang Chen; Fengjin Ma
Journal:  Front Neurol       Date:  2020-11-20       Impact factor: 4.003

Review 5.  Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs.

Authors:  Catia Giovannini; Francesca Fornari; Fabio Piscaglia; Laura Gramantieri
Journal:  Cells       Date:  2021-03-01       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.